A Phase Ib Clinical Study on the Safety and Efficacy of HC010 Combinations in Advanced Solid Tumors
Phase 1 Recruiting
331 enrolled
Study of Ociperlimab (BGB-A1217) in Combination With Tislelizumab in Advanced Solid Tumors
Phase 1 Completed
446 enrolled 49 charts
Imatinib Mesylate, Gemcitabine, and Capecitabine in Treating Patients With Advanced Solid Tumors
Phase 1 Completed
13 enrolled
Tolerability and Bioavailability of Utidelone Capsule in Patients With Advanced Solid Tumors
Phase 1 Recruiting
84 enrolled
A Study of Mitoxantrone Hydrochloride Liposome Injection Combination Therapy in Chinese Patients With Advanced Solid Tumors
Phase 1 Unknown
116 enrolled
A Study of HB002.1T Plus Chemotherapy in Subjects With Solid Tumor
Phase 1 Unknown
72 enrolled
A Study of the Safety and Efficacy of Atezolizumab Administered in Combination With Bevacizumab and/or Other Treatments in Participants With Solid Tumors
Phase 1 Completed
243 enrolled
ASLAN001 in Combination With Oxaliplatin and Capecitabine or Oxaliplatin and 5-FU With Leucovorin
Phase 1 Unknown
60 enrolled
LY317615 Plus Capecitabine in Treating Patients With Advanced Solid Tumors
Phase 1 Completed
16 enrolled
A Study Of Neratinib (HKI-272) And Capecitabine In Japanese With Solid Tumor
Phase 1 Completed
7 enrolled 13 charts
Capecitabine or 5-Fluorouracil in Combination With Irinotecan and Cisplatin in Patients With Solid Tumor Malignancies
Phase 1 Completed
54 enrolled
Safety and Tolerability of ASLAN001 in Combination With Cisplatin and 5-FU or Cisplatin and Capecitabine
Phase 1 Completed
31 enrolled
Capecitabine and Celecoxib in Patients With Solid Cancers That Have Been Previously Treated With Standard Therapies
Phase 1 Terminated
21 enrolled 5 charts
A Phase Ib, Open-label, Multicenter Study of the Safety and PK of the Combination of rhuMAb2c4 (Omnitarg), a Recombinant Humanized Antibody to HER2, and Capecitabine (Xeloda) in Patients With Advanced Solid Tumors
Phase 1 Completed
19 enrolled 16 charts
High-Selenium Brassica Juncea, Irinotecan, and Capecitabine in Treating Patients With Advanced Cancer
Phase 1 Completed
22 enrolled
Vorinostat and Capecitabine in Treating Patients With Metastatic or Unresectable Solid Tumors
Phase 1 Completed
28 enrolled
Oxaliplatin Plus Capecitabine in Treating Patients With Metastatic or Recurrent Solid Tumor
Phase 1 Completed
Phase I of OratecanTM in Combination With Capecitabine in Patients With Advanced Solid Malignancies
Phase 1 Completed
21 enrolled 10 charts
A Study of Temsirolimus Plus Capecitabine in Patients With Advanced Cancer
Phase 1 Completed
47 enrolled
Combination Chemotherapy in Treating Patients With Advanced Cancer That is Metastatic or Cannot Be Removed By Surgery
Phase 1 Completed
50 enrolled
Irinotecan, Oxaliplatin, and Capecitabine in Treating Patients With Unresectable Solid Tumors
Phase 1 Completed
84 enrolled
Imatinib Mesylate and Capecitabine in Treating Patients With Advanced Solid Tumors
Phase 1 Completed
25 enrolled
Gefitinib and Capecitabine in Treating Patients With Advanced Solid Tumors
Phase 1 Completed
41 enrolled
Study of Capecitabine In Patients With Solid Tumors
Phase 1 Completed
23 enrolled
A Study of Tesetaxel Plus Capecitabine in Patients With Solid Tumors
Phase 1 Unknown
9 enrolled
DJ-927 and Capecitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors
Phase 1 Completed
Combination Chemotherapy in Treating Patients With Advanced Solid Tumors
Phase 1 Completed
22 enrolled
Ispinesib In Combination With Capecitabine In Patients With Solid Tumors
Phase 1 Completed
30 enrolled